Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium Channels, T-Type | 10 | 2019 | 28 | 3.020 |
Why?
|
| Ethanol | 12 | 2023 | 195 | 2.570 |
Why?
|
| Geniculate Bodies | 20 | 2006 | 23 | 2.190 |
Why?
|
| Thalamus | 8 | 2010 | 36 | 1.870 |
Why?
|
| Alcohol Withdrawal Seizures | 3 | 2023 | 3 | 1.760 |
Why?
|
| Neurons | 15 | 2017 | 486 | 1.750 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2023 | 76 | 1.700 |
Why?
|
| Alcoholism | 5 | 2023 | 97 | 1.590 |
Why?
|
| Neural Pathways | 9 | 2018 | 112 | 1.550 |
Why?
|
| Receptors, Metabotropic Glutamate | 7 | 2013 | 23 | 1.370 |
Why?
|
| Magnetoencephalography | 5 | 2021 | 12 | 1.340 |
Why?
|
| Seizures | 4 | 2023 | 65 | 1.300 |
Why?
|
| Ethosuximide | 3 | 2015 | 3 | 1.250 |
Why?
|
| Animals | 48 | 2023 | 8199 | 1.230 |
Why?
|
| Calcium Channel Blockers | 4 | 2019 | 53 | 1.210 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2019 | 39 | 1.140 |
Why?
|
| Cerebral Cortex | 5 | 2012 | 143 | 1.010 |
Why?
|
| Nerve Net | 4 | 2021 | 137 | 1.000 |
Why?
|
| Brain | 5 | 2021 | 965 | 0.970 |
Why?
|
| Central Nervous System Depressants | 6 | 2021 | 63 | 0.960 |
Why?
|
| Mice | 15 | 2023 | 2571 | 0.950 |
Why?
|
| Electroencephalography | 4 | 2017 | 75 | 0.900 |
Why?
|
| Nitric Oxide | 7 | 2006 | 121 | 0.850 |
Why?
|
| Brain Mapping | 5 | 2018 | 190 | 0.820 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2022 | 42 | 0.800 |
Why?
|
| Nitric Oxide Synthase | 6 | 2009 | 41 | 0.770 |
Why?
|
| Pentylenetetrazole | 3 | 2019 | 3 | 0.750 |
Why?
|
| Action Potentials | 7 | 2019 | 212 | 0.730 |
Why?
|
| Status Epilepticus | 2 | 2013 | 20 | 0.700 |
Why?
|
| Brain Concussion | 2 | 2022 | 41 | 0.670 |
Why?
|
| Pyramidal Cells | 1 | 2019 | 18 | 0.610 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 2 | 2012 | 8 | 0.600 |
Why?
|
| Visual Pathways | 7 | 2002 | 42 | 0.590 |
Why?
|
| Glutamic Acid | 3 | 2012 | 50 | 0.590 |
Why?
|
| Synapses | 6 | 2009 | 87 | 0.580 |
Why?
|
| Benzamides | 1 | 2018 | 60 | 0.560 |
Why?
|
| Piperidines | 1 | 2018 | 137 | 0.530 |
Why?
|
| Rest | 1 | 2017 | 48 | 0.500 |
Why?
|
| Feedback | 3 | 2006 | 41 | 0.500 |
Why?
|
| Ferrets | 6 | 2006 | 20 | 0.480 |
Why?
|
| Optical Fibers | 2 | 2014 | 4 | 0.460 |
Why?
|
| Male | 20 | 2019 | 19443 | 0.450 |
Why?
|
| Intralaminar Thalamic Nuclei | 3 | 2005 | 3 | 0.430 |
Why?
|
| Wakefulness | 1 | 2014 | 25 | 0.410 |
Why?
|
| Pilocarpine | 1 | 2013 | 6 | 0.410 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 8 | 0.410 |
Why?
|
| Movement | 1 | 2014 | 61 | 0.400 |
Why?
|
| Electromyography | 1 | 2013 | 67 | 0.400 |
Why?
|
| Protein Kinase C | 1 | 2013 | 43 | 0.380 |
Why?
|
| Sleep Stages | 1 | 2012 | 5 | 0.380 |
Why?
|
| Channelopathies | 2 | 2010 | 3 | 0.380 |
Why?
|
| Neuronal Plasticity | 2 | 2010 | 84 | 0.370 |
Why?
|
| Brain Stem | 3 | 2009 | 22 | 0.360 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 853 | 0.360 |
Why?
|
| Mice, Inbred DBA | 3 | 2018 | 42 | 0.360 |
Why?
|
| Receptors, Serotonin | 1 | 2012 | 10 | 0.360 |
Why?
|
| Anticonvulsants | 4 | 2019 | 59 | 0.350 |
Why?
|
| Gene Expression | 3 | 2010 | 346 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 792 | 0.340 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 2010 | 2 | 0.330 |
Why?
|
| Biological Clocks | 1 | 2010 | 6 | 0.330 |
Why?
|
| Ion Channels | 1 | 2010 | 26 | 0.320 |
Why?
|
| Stress, Psychological | 1 | 2012 | 217 | 0.310 |
Why?
|
| Luminescent Proteins | 2 | 2021 | 25 | 0.310 |
Why?
|
| Visual Cortex | 3 | 2005 | 46 | 0.300 |
Why?
|
| Cats | 13 | 2003 | 135 | 0.300 |
Why?
|
| Electric Stimulation | 7 | 2009 | 135 | 0.300 |
Why?
|
| Models, Neurological | 3 | 2021 | 139 | 0.300 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 93 | 0.290 |
Why?
|
| Epilepsy | 1 | 2010 | 79 | 0.290 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 257 | 0.270 |
Why?
|
| Synaptic Transmission | 6 | 2006 | 124 | 0.260 |
Why?
|
| Animals, Newborn | 7 | 2006 | 136 | 0.250 |
Why?
|
| Epilepsy, Absence | 1 | 2006 | 1 | 0.250 |
Why?
|
| Patch-Clamp Techniques | 6 | 2009 | 76 | 0.240 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 46 | 0.240 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2006 | 33 | 0.230 |
Why?
|
| Glycine | 1 | 2005 | 26 | 0.220 |
Why?
|
| Neural Inhibition | 1 | 2005 | 33 | 0.220 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 39 | 0.220 |
Why?
|
| Amino Acids | 3 | 2013 | 52 | 0.210 |
Why?
|
| Evoked Potentials | 2 | 2021 | 17 | 0.210 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2021 | 47 | 0.210 |
Why?
|
| Photic Stimulation | 6 | 1999 | 167 | 0.200 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 478 | 0.200 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 545 | 0.200 |
Why?
|
| Penicillamine | 2 | 2006 | 2 | 0.200 |
Why?
|
| Random Allocation | 2 | 2014 | 247 | 0.200 |
Why?
|
| Sleep | 1 | 2003 | 84 | 0.190 |
Why?
|
| Nitrergic Neurons | 1 | 2002 | 1 | 0.180 |
Why?
|
| Neurofilament Proteins | 2 | 2000 | 17 | 0.180 |
Why?
|
| Body Patterning | 1 | 2002 | 4 | 0.180 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 74 | 0.180 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2003 | 82 | 0.180 |
Why?
|
| Calcium | 4 | 2019 | 339 | 0.180 |
Why?
|
| Veterans | 1 | 2022 | 64 | 0.180 |
Why?
|
| Drug Interactions | 3 | 2006 | 86 | 0.180 |
Why?
|
| Humans | 11 | 2023 | 32284 | 0.180 |
Why?
|
| Bicuculline | 3 | 1993 | 10 | 0.180 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2001 | 2 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2023 | 204 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 717 | 0.170 |
Why?
|
| Neurotransmitter Agents | 2 | 2000 | 35 | 0.170 |
Why?
|
| Female | 7 | 2021 | 19947 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2003 | 461 | 0.160 |
Why?
|
| Interneurons | 6 | 2003 | 24 | 0.160 |
Why?
|
| Convulsants | 1 | 2019 | 3 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2021 | 178 | 0.150 |
Why?
|
| Tupaiidae | 2 | 1989 | 2 | 0.150 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 15 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 65 | 0.140 |
Why?
|
| Vision, Monocular | 1 | 1998 | 1 | 0.140 |
Why?
|
| Sensory Deprivation | 1 | 1998 | 15 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1083 | 0.140 |
Why?
|
| Hospitalization | 1 | 2021 | 475 | 0.140 |
Why?
|
| Retina | 2 | 1996 | 86 | 0.140 |
Why?
|
| Nitroso Compounds | 1 | 1998 | 2 | 0.140 |
Why?
|
| Light | 1 | 1998 | 35 | 0.140 |
Why?
|
| Membranes, Artificial | 1 | 1998 | 8 | 0.140 |
Why?
|
| Microscopy, Electron | 4 | 2003 | 43 | 0.140 |
Why?
|
| Parvalbumins | 1 | 2017 | 10 | 0.140 |
Why?
|
| Electromagnetic Fields | 1 | 2018 | 26 | 0.140 |
Why?
|
| Glass | 2 | 1998 | 2 | 0.140 |
Why?
|
| Glutathione | 1 | 1998 | 54 | 0.130 |
Why?
|
| Dendrites | 4 | 2003 | 17 | 0.130 |
Why?
|
| Nitric Oxide Donors | 3 | 2006 | 8 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 62 | 0.130 |
Why?
|
| Macaca mulatta | 3 | 2012 | 340 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2012 | 413 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 164 | 0.130 |
Why?
|
| Iontophoresis | 2 | 1996 | 7 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2018 | 75 | 0.130 |
Why?
|
| Membrane Potentials | 3 | 2006 | 76 | 0.130 |
Why?
|
| Equipment Design | 2 | 2014 | 178 | 0.120 |
Why?
|
| Contrast Media | 1 | 2017 | 136 | 0.120 |
Why?
|
| Rats | 4 | 2006 | 1895 | 0.120 |
Why?
|
| Xanthenes | 2 | 2006 | 4 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 28 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 246 | 0.120 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2006 | 83 | 0.120 |
Why?
|
| Evoked Potentials, Visual | 2 | 2014 | 6 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 255 | 0.110 |
Why?
|
| Photolysis | 3 | 1999 | 4 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2006 | 499 | 0.110 |
Why?
|
| Macaca fascicularis | 2 | 2006 | 542 | 0.110 |
Why?
|
| Mortality | 1 | 2015 | 122 | 0.100 |
Why?
|
| Biophysics | 1 | 2014 | 13 | 0.100 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 54 | 0.100 |
Why?
|
| Tungsten | 1 | 1993 | 2 | 0.100 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 121 | 0.100 |
Why?
|
| Electrodes | 1 | 1993 | 20 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 131 | 0.100 |
Why?
|
| Central Nervous System | 1 | 1993 | 47 | 0.100 |
Why?
|
| Time Factors | 3 | 2018 | 2205 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2013 | 60 | 0.100 |
Why?
|
| Acute Disease | 1 | 2013 | 253 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 83 | 0.090 |
Why?
|
| Maternal Deprivation | 1 | 2012 | 3 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2013 | 299 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2013 | 553 | 0.090 |
Why?
|
| Electrophysiology | 4 | 1999 | 76 | 0.090 |
Why?
|
| Neoplasms | 1 | 2018 | 754 | 0.080 |
Why?
|
| Adult | 3 | 2018 | 9259 | 0.080 |
Why?
|
| Afferent Pathways | 3 | 2000 | 40 | 0.080 |
Why?
|
| Cell Size | 4 | 2003 | 40 | 0.080 |
Why?
|
| Thalamic Nuclei | 2 | 2001 | 5 | 0.080 |
Why?
|
| Olfactory Bulb | 1 | 2009 | 3 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 15 | 0.080 |
Why?
|
| NADPH Dehydrogenase | 1 | 2009 | 3 | 0.070 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2009 | 11 | 0.070 |
Why?
|
| Middle Aged | 3 | 2018 | 11853 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 95 | 0.070 |
Why?
|
| Somatosensory Cortex | 1 | 2009 | 30 | 0.070 |
Why?
|
| Nitroprusside | 2 | 1999 | 5 | 0.070 |
Why?
|
| Pulvinar | 2 | 2003 | 2 | 0.060 |
Why?
|
| Glutamate Decarboxylase | 2 | 2003 | 17 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 17 | 0.060 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 13 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 18 | 0.060 |
Why?
|
| Arginine | 1 | 2006 | 23 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2006 | 23 | 0.060 |
Why?
|
| Triazoles | 1 | 2006 | 15 | 0.060 |
Why?
|
| Epilepsy, Generalized | 1 | 2006 | 3 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2006 | 27 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 41 | 0.060 |
Why?
|
| Guanosine Diphosphate | 1 | 2006 | 4 | 0.060 |
Why?
|
| Picrotoxin | 1 | 2006 | 3 | 0.060 |
Why?
|
| Gluconates | 1 | 2006 | 4 | 0.060 |
Why?
|
| Thionucleotides | 1 | 2006 | 5 | 0.060 |
Why?
|
| Visual Perception | 2 | 1999 | 121 | 0.060 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 30 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1479 | 0.060 |
Why?
|
| Receptors, Glutamate | 1 | 2005 | 6 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2006 | 109 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 49 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 44 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 174 | 0.060 |
Why?
|
| Axons | 2 | 2003 | 35 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2006 | 299 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 276 | 0.060 |
Why?
|
| Reaction Time | 1 | 2005 | 123 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 471 | 0.060 |
Why?
|
| Cyclopropanes | 1 | 2005 | 13 | 0.060 |
Why?
|
| Acetylcholine | 2 | 2000 | 69 | 0.050 |
Why?
|
| Afghan Campaign 2001- | 1 | 2022 | 10 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2001 | 7 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2021 | 78 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 153 | 0.040 |
Why?
|
| Critical Care | 1 | 2021 | 108 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2001 | 308 | 0.040 |
Why?
|
| Xenon | 1 | 1999 | 3 | 0.040 |
Why?
|
| Fiber Optic Technology | 1 | 1999 | 13 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 80 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 79 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 114 | 0.040 |
Why?
|
| Radiometry | 1 | 2019 | 52 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 112 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 897 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 1224 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 1998 | 20 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 1998 | 40 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 96 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1998 | 63 | 0.030 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 1998 | 1 | 0.030 |
Why?
|
| S-Nitrosoglutathione | 1 | 1998 | 5 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1998 | 22 | 0.030 |
Why?
|
| Solutions | 1 | 1998 | 40 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1998 | 20 | 0.030 |
Why?
|
| Reference Values | 1 | 1998 | 238 | 0.030 |
Why?
|
| Alcoholic Intoxication | 1 | 2017 | 28 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 167 | 0.030 |
Why?
|
| Nerve Endings | 1 | 1996 | 4 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1996 | 64 | 0.030 |
Why?
|
| Cycloleucine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Military Personnel | 1 | 2018 | 103 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 63 | 0.030 |
Why?
|
| Primates | 1 | 2017 | 128 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1996 | 16 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 258 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 757 | 0.030 |
Why?
|
| Self Administration | 1 | 2017 | 382 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 942 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 603 | 0.030 |
Why?
|
| Norepinephrine | 2 | 2009 | 101 | 0.030 |
Why?
|
| ROC Curve | 1 | 1995 | 169 | 0.030 |
Why?
|
| Lateral Thalamic Nuclei | 2 | 2003 | 2 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 232 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1996 | 727 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 1993 | 104 | 0.020 |
Why?
|
| Visual Fields | 1 | 1992 | 29 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2649 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3416 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1992 | 64 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3628 | 0.020 |
Why?
|
| Sex Attractants | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium Channels, R-Type | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium Channels, N-Type | 1 | 2009 | 3 | 0.020 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2009 | 8 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2009 | 8 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2009 | 18 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 67 | 0.020 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2009 | 7 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 40 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 35 | 0.020 |
Why?
|
| Fingers | 1 | 2009 | 75 | 0.020 |
Why?
|
| Pons | 1 | 2000 | 7 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2000 | 10 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1997 | 14 | 0.010 |
Why?
|